GMP Audits & Gap Assessments
In the highly regulated pharmaceutical, biotechnology, and medical device industries, maintaining continuous GMP compliance is non-negotiable—yet even mature quality systems can develop hidden vulnerabilities. Our GMP Audits & Gap Assessments deliver a comprehensive, risk-based evaluation of your manufacturing, quality control, and documentation practices against current regulatory expectations (FDA, EMA, and global standards). Unlike routine checklists, our expert auditors dissect your end-to-end operations—from raw material sourcing to batch release—to uncover systemic deviations, data integrity risks, and procedural weaknesses before they trigger enforcement actions. We pair rigorous, impartial GMP auditing with actionable gap assessments that prioritize findings by patient safety and regulatory impact.
Crucially, we don’t just flag deficiencies; we translate each gap into a strategic, cost-effective remediation roadmap that aligns with your business timelines, whether you are preparing for a pre-approval inspection, responding to a Form 483, or rebuilding a QMS after a compliance setback. By integrating these dual services, you gain a clear, defensible picture of your current state, a prioritized CAPA plan, and the confidence to face any regulatory scrutiny—transforming compliance from a reactive burden into a competitive advantage that accelerates time-to-market and safeguards brand reputation.
Contact us now if you are looking for:
- GMP Audits
- Gap Assessments
- Quality System Audits
- Supplier/Vendor Audits
- Data Integrity Audits
- Gap Analysis & CAPA Implementation
- QMS Rebuilding
- Documentation & SOP Development
- Process Validation
- Computer System Validation

